rheumatoid arthritis and semaglutide Chondroprotective Effect of Semaglutide in Osteoarthritis: Association with Macrophage Polarization ACR 2025: GLP-1 Drugs Reduce

Medicare does not cover weight-management indications for weight alone as of April 2026, though some products carry cardiovascular-indication coverage

We typically prescribe Wegovy as part of a comprehensive weight management plan

The restrictions differ by country: for example, in Japan, a person has to stop taking etretinate for at least 2 years before becoming eligible to donate blood, but in the United States, the United Kingdom, and Quebec, its a permanent restriction

Such effects are beneficial for people with Type 2 diabetes, as improved insulin resistance can lead to better glycemic control and reduced risk of diabetes-related complications

Some patients do extremely well on Wegovy